Fig. 4.
Fig. 4. Engraftment of human fetal thymic and BM tissue implanted in SCID mice by CD4− CD34++ Lin− LDFL and CD4+ CD34++ Lin− LDFL progenitors. Generation of CD3+, CD4 SP, and CD8 SP and DP thymocytes by 50 HLA-A3− CD4+ CD34++ Lin− LDFL cells injected into an HLA-A3+ thymic implant 95 days before analysis. Note the presence of a small (<1.9%) fraction of CD3+ HLA-A3+ host cells (A). Generation of CD34+, CD19+, and CD33+ cells by 200 HLA-A3+ CD4+ CD34++ Lin− LDFL cells injected into human fetal bone fragments (HLA-A3−) 125 days before analysis (B). The data are shown using 3% (A) and 2% (B) linear-density contour plots with 1 degree of smoothing. Analysis of CD4 and CD34 expression on Lin− PI− LDFL cells before (C, left) and after FACS (C, center and right). Ten thousand PI− events were collected for the sort reanalysis shown. These sorted cells are donor B in Table 2 and donor D in Table 3.

Engraftment of human fetal thymic and BM tissue implanted in SCID mice by CD4 CD34++ Lin LDFL and CD4+ CD34++ Lin LDFL progenitors. Generation of CD3+, CD4 SP, and CD8 SP and DP thymocytes by 50 HLA-A3 CD4+ CD34++ Lin LDFL cells injected into an HLA-A3+ thymic implant 95 days before analysis. Note the presence of a small (<1.9%) fraction of CD3+ HLA-A3+ host cells (A). Generation of CD34+, CD19+, and CD33+ cells by 200 HLA-A3+ CD4+ CD34++ Lin LDFL cells injected into human fetal bone fragments (HLA-A3) 125 days before analysis (B). The data are shown using 3% (A) and 2% (B) linear-density contour plots with 1 degree of smoothing. Analysis of CD4 and CD34 expression on Lin PI LDFL cells before (C, left) and after FACS (C, center and right). Ten thousand PI events were collected for the sort reanalysis shown. These sorted cells are donor B in Table 2 and donor D in Table 3.

Close Modal

or Create an Account

Close Modal
Close Modal